These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 23738523

  • 1. Bridging the gap between osteoporosis and osteonecrosis of the jaw: preventing and treating BRONJ with MK4.
    Neustadt J, Pieczenik S.
    Compend Contin Educ Dent; 2011 Oct; 32(8):e125-31. PubMed ID: 23738523
    [Abstract] [Full Text] [Related]

  • 2. [Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].
    Yoneda T.
    Clin Calcium; 2014 Mar; 24(3):407-15. PubMed ID: 24576938
    [Abstract] [Full Text] [Related]

  • 3. Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?
    Lescaille G, Coudert AE, Baaroun V, Javelot MJ, Cohen-Solal M, Berdal A, Goudot P, Azérad J, Ruhin B, Descroix V.
    J Rheumatol; 2013 Jun; 40(6):781-6. PubMed ID: 23504384
    [Abstract] [Full Text] [Related]

  • 4. Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
    Di Fede O, Fusco V, Matranga D, Solazzo L, Gabriele M, Gaeta GM, Favia G, Sprini D, Peluso F, Colella G, Vescovi P, Campisi G.
    Eur J Intern Med; 2013 Dec; 24(8):784-90. PubMed ID: 23768563
    [Abstract] [Full Text] [Related]

  • 5. Dental implications of bisphophonate-related osteonecrosis.
    Saldanha S, Shenoy VK, Eachampati P, Uppal N.
    Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
    [Abstract] [Full Text] [Related]

  • 6. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.
    Utreja A, Almas K, Javed F.
    Odontostomatol Trop; 2013 Jun; 36(142):38-46. PubMed ID: 24073539
    [Abstract] [Full Text] [Related]

  • 7. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
    Vescovi P, Nammour S.
    Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
    [Abstract] [Full Text] [Related]

  • 8. [Vitamin D and bisphosphonate-related osteonecrosis of the jaw (BRONJ) ].
    Hokugo A.
    Clin Calcium; 2012 Jan; 22(1):83-90. PubMed ID: 22201103
    [Abstract] [Full Text] [Related]

  • 9. Knowledge, practices, and opinions of ontario dentists when treating patients receiving bisphosphonates.
    Alhussain A, Peel S, Dempster L, Clokie C, Azarpazhooh A.
    J Oral Maxillofac Surg; 2015 Jun; 73(6):1095-105. PubMed ID: 25843818
    [Abstract] [Full Text] [Related]

  • 10. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates].
    Endo Y, Funayama H, Yamaguchi K, Monma Y, Yu Z, Deng X, Oizumi T, Shikama Y, Tanaka Y, Okada S, Kim S, Kiyama T, Bando K, Shima K, Suzuki H, Takahashi T.
    Yakugaku Zasshi; 2020 Aug; 140(1):63-79. PubMed ID: 31902887
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Current situation and future issues of antiresorptive agent-related osteonecrosis of the jaw].
    Takaoka K, Kishimoto H.
    Nihon Yakurigaku Zasshi; 2019 Aug; 153(1):22-27. PubMed ID: 30643088
    [Abstract] [Full Text] [Related]

  • 15. Antiresorptives and osteonecrosis of the jaw.
    Yamashita J, McCauley LK.
    J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):233-47. PubMed ID: 23040351
    [Abstract] [Full Text] [Related]

  • 16. Underlying Mechanisms and Therapeutic Strategies for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
    Endo Y, Kumamoto H, Nakamura M, Sugawara S, Takano-Yamamoto T, Sasaki K, Takahashi T.
    Biol Pharm Bull; 2017 Sep; 40(6):739-750. PubMed ID: 28566618
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [Abstract] [Full Text] [Related]

  • 19. The role of bisphosphonates in medical oncology and their association with jaw bone necrosis.
    Eid A, Atlas J.
    Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):231-7. PubMed ID: 24794267
    [Abstract] [Full Text] [Related]

  • 20. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER, Basile JD.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.